CRIS Current Research Information System

MURATORI, PAOLO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 7.840
AS - Asia 6.772
EU - Europa 5.098
AF - Africa 411
SA - Sud America 330
OC - Oceania 19
Totale 20.470
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 7.759
VN - Vietnam 2.140
CN - Cina 1.709
SG - Singapore 1.677
GB - Regno Unito 1.312
IT - Italia 787
DE - Germania 719
SE - Svezia 629
HK - Hong Kong 372
FR - Francia 323
IN - India 318
UA - Ucraina 304
RU - Federazione Russa 262
BR - Brasile 205
IE - Irlanda 169
JP - Giappone 125
NL - Olanda 112
FI - Finlandia 103
ZA - Sudafrica 102
KR - Corea 95
EE - Estonia 86
CI - Costa d'Avorio 83
SC - Seychelles 74
TG - Togo 70
CH - Svizzera 65
AR - Argentina 60
PH - Filippine 51
CA - Canada 46
BG - Bulgaria 34
TR - Turchia 34
AT - Austria 32
BD - Bangladesh 31
TH - Thailandia 31
BE - Belgio 30
JO - Giordania 30
PL - Polonia 28
ID - Indonesia 27
IQ - Iraq 25
EC - Ecuador 22
MX - Messico 22
NG - Nigeria 21
GR - Grecia 20
PK - Pakistan 19
TW - Taiwan 17
HR - Croazia 16
RO - Romania 13
AU - Australia 12
EG - Egitto 12
ES - Italia 12
MA - Marocco 12
IR - Iran 11
SA - Arabia Saudita 11
TN - Tunisia 11
KE - Kenya 8
LT - Lituania 8
MY - Malesia 8
VE - Venezuela 8
CL - Cile 7
CO - Colombia 7
PT - Portogallo 7
UZ - Uzbekistan 7
CZ - Repubblica Ceca 6
NZ - Nuova Zelanda 6
PE - Perù 6
PY - Paraguay 6
DZ - Algeria 5
OM - Oman 5
AO - Angola 4
BO - Bolivia 4
LB - Libano 4
NP - Nepal 4
SK - Slovacchia (Repubblica Slovacca) 4
SN - Senegal 4
SY - Repubblica araba siriana 4
UY - Uruguay 4
AL - Albania 3
CR - Costa Rica 3
NO - Norvegia 3
AE - Emirati Arabi Uniti 2
AM - Armenia 2
AZ - Azerbaigian 2
BY - Bielorussia 2
DK - Danimarca 2
IL - Israele 2
JM - Giamaica 2
KZ - Kazakistan 2
LV - Lettonia 2
MK - Macedonia 2
PS - Palestinian Territory 2
AG - Antigua e Barbuda 1
BA - Bosnia-Erzegovina 1
BZ - Belize 1
CG - Congo 1
CY - Cipro 1
DM - Dominica 1
DO - Repubblica Dominicana 1
FK - Isole Falkland (Malvinas) 1
GA - Gabon 1
GH - Ghana 1
GL - Groenlandia 1
Totale 20.458
Salva come PNG Salva come JPEG
Città #
Singapore 1.145
Southend 1.129
Fairfield 828
Ashburn 801
Chandler 595
Dong Ket 585
Woodbridge 402
Houston 390
Seattle 386
Santa Clara 376
Ho Chi Minh City 371
Wilmington 352
Hong Kong 347
Hanoi 328
San Jose 325
Cambridge 294
Princeton 253
Ann Arbor 247
Hefei 212
Beijing 194
Jacksonville 194
Boardman 170
Dublin 168
Bologna 142
Lauterbourg 117
Nanjing 116
Tokyo 107
Padova 103
Westminster 101
Frankfurt am Main 95
Berlin 91
Los Angeles 91
Helsinki 86
Jinan 85
Abidjan 83
Lomé 70
Seoul 69
Da Nang 65
Buffalo 61
Shenyang 60
Haiphong 58
Milan 54
Council Bluffs 53
Saint Petersburg 53
Bern 52
San Diego 51
Dallas 49
New York 48
Changsha 44
Des Moines 42
Hebei 40
Bremen 39
Mülheim 39
Guangzhou 37
Nanchang 35
Shanghai 35
Tianjin 34
Sofia 32
Turin 31
Amman 30
Redondo Beach 30
Rome 30
Brussels 28
Zhengzhou 28
Munich 27
Phoenix 27
London 26
Hangzhou 25
Bengaluru 24
Medford 24
São Paulo 23
Haikou 21
Abeokuta 20
Chengdu 20
Mahé 20
Can Tho 19
Falls Church 19
Hải Dương 19
Jiaxing 19
Taiyuan 19
Vienna 19
Dearborn 18
Nuremberg 18
Bühl 17
Chicago 17
Orem 17
Washington 17
Amsterdam 16
Biên Hòa 16
Taizhou 16
Fremont 15
Fuzhou 15
Modena 15
Ningbo 15
Ninh Bình 15
Verona 15
Moscow 14
Thái Nguyên 14
Toronto 14
Warsaw 14
Totale 13.275
Salva come PNG Salva come JPEG
Nome #
Anti-Saccharomyces cerevisiae and perinuclear anti-neutrophil antibodies in coeliac disease before and after gluten free diet. 297
A multifaceted imbalance of T cells with regulatory function characterizes type 1 autoimmune hepatitis 273
COVID-19 and Immunological Dysregulation: Can Autoantibodies be Useful? 268
Antibodies to SS-A/Ro-52kD and centromere in autoimmune liver disease: a clue to diagnosis and prognosis of primary biliary cirrhosis. 254
Imaging-based diagnosis of benign lesions and pseudolesions in the cirrhotic liver 253
Type 1 autoimmune hepatitis: patterns of clinical presentation and differential diagnosis of the 'acute' type. 252
Clinical and serological profile of primary biliary cirrhosis in men. 239
Antinuclear antibodies in COVID 19 237
'True' antimitochondrial antibody-negative primary biliary cirrhosis, low sensitivity of the routine assays, or both? 235
Antinuclear antibodies as ancillary markers in primary biliary cirrhosis. 235
Clinical features of type 1 autoimmune hepatitis in elderly Italian patients 233
Anti-nuclear antibodies giving the “multiple nuclear dots” (MND) or the “rim-like/membranous” (RL/M) patterns: diagnostic accuracy for primary biliary cirrhosis. 232
Autoimmune liver disease and concomitant extrahepatic autoimmune disease 227
Application of the 2010 American Association for the study of liver diseases criteria of remission to a cohort of Italian patients with autoimmune hepatitis. 224
A COMPLEX IMMUNOREGULATORY DEFICIENCY CHARACTERISES TYPE 1 AUTOIMMUNE HEPATITIS. 224
Autoimmune enteropathy and rheumatoid arthritis: A new association in the field of autoimmunity. 216
Clinical impact of non-organ-specific autoantibodies on the response to combined antiviral treatment in patients with hepatitis C 214
Anti-actin IgA antibodies in severe coeliac disease 214
SPECIFICITY OF ANTI-SP100 ANTIBODY FOR PRIMARY BILIARY CIRRHOSIS. 209
Multiple nuclear dots and rim-like/membranous IgG isotypes in primary biliary cirrhosis. 206
Autoimmune liver disease in patients with systemic lupus erythematosus: a retrospective analysis of 147 cases. 204
Direct acting antivirals for the treatment of elderly patients with HCV advanced disease in the real life practice 203
Treatment with direct acting antiviral agents-based regimen in HCV patients with advanced liver disease: Analysis of an Italian multicenter observational study 201
Antimitochondrial antibodies positive autoimmune hepatitis with acute onset 200
Acute icteric hepatitis induced by a short course of low-dose cyclophosphamide in a patient with lupus nephritis 198
A case of leptospirosis simulating colon cancer with liver metastases 196
Autoantibodies in Autoimmune Hepatitis 195
Clinical Impact and behaviour of serum autoantibodies in adult liver transplantation 195
Features and Progression of Asymptomatic Autoimmune Hepatitis in Italy 194
Virological analysis, genotypes and mutational patterns of the HBV pre-core/core gene in HBV/HCV-related hepatocellular carcinoma. 193
Imbalance of Neutrophils and Lymphocyte Counts Can Be Predictive of Hepatocellular Carcinoma Occurrence in Hepatitis C-related Cirrhosis Treated With Direct-acting Antivirals 193
Genome-wide meta-analyses identify three loci associated with primary biliary cirrhosis 192
CLINICAL FEATURES OF PRIMARY BILIARY CIRRHOSIS IN YOUNG AND ELDERLY PATIENTS. 192
Antibodies to soluble liver antigen in patients with various liver diseases: A multicentre study 186
X Chromosome Contribution to the Genetic Architecture of Primary Biliary Cholangitis 185
Diagnosis and therapy of autoimmune hepatitis. 184
Lack of complete biochemical response in autoimmune hepatitis leads to adverse outcome: First report of the IAIHG retrospective registry 183
Autoimmune liver disease 2007. 182
Type 1 and type 2 autoimmune hepatitis in adults share the same clinical phenotype 182
Antibodies to filamentous actin (F-actin) in type 1 autoimmune hepatitis. 182
Clinical and prognostic implications of acute onset of Autoimmune Hepatitis: An Italian multicentre study 179
Blood-Based Non-Invasive Tests of Hepatic Fibrosis in Autoimmune Hepatitis: Application among Selected Patients Leads to Higher Accuracy 178
Autoimmune hepatitis in Italy: the Bologna experience. 177
Clinical implications of antimitochondrial antibody seropositivity in autoimmune hepatitis: a multicentre study 176
PML nuclear body component Sp140 is a novel autoantigen in primary biliary cirrhosis. 175
Anti-saccharomyces cerevisiae antibodies (ASCA) in coeliac disease. 173
Antimitochondrial antibodies and other antibodies in primary biliary cirrhosis: diagnostic and prognostic value 172
An international genome-wide meta-analysis of primary biliary cholangitis: Novel risk loci and candidate drugs 172
Primary biliary cirrhosis specific anti-nuclear antibodies in patients from Spain. 171
Clinical features and effect of antiviral therapy on anti-liver/kidney microsomal antibody type 1 positive chronic hepatitis C. 171
Redistribution of regulatory T-cells across the evolving stages of chronic hepatitis C. 169
Antifilamentous Actin Antibodies by ELISA for the Diagnosis of Type 1 Autoimmune Hepatitis. 169
Clinical and serological profile of primary biliary cirrhosis in young and elderly patients. 168
The western immunoblotting pattern of anti-mitochondrial antibodies is independent of the clinical expression of primary biliary cirrhosis 168
Antitransglutaminase antibodies and giardiasis 167
Specific antinuclear reactivities in primary biliary cirrhosis 165
PML NUCLEAR BODY COMPONENT SP140 IS A NOVEL AUTOANTIGEN IN PRIMARY BILIARY CIRRHOSIS. 165
Anti-ribosomal P protein antibody: an autoreactivity devoid of prognostic value in patients with autoimmune hepatitis. 165
Overcoming a "probable" diagnosis in antimitochondrial antibody negative primary biliary cirrhosis: study of 100 sera and review of the literature. 164
Deamidated gliadin Peptide antibodies as a routine test for celiac disease: a prospective analysis. 164
Immunoglobulin GM and KM allotypes and prevalence of anti-LKM1 autoantibodies in patients with hepatitis C virus infection. 160
INCREASED REGULATORY POTENTIAL AND IMBALANCE OF THE VDELTA1/VDELTA2 RATIO IN PATIENTS WITH DIFFERENT MANIFESTATIONS OF HEPATITIS C. 160
Celiac disease in autoimmune cholestatic liver disorders 159
The serological profile of the autoimmune hepatitis/primary biliary cirrhosis overlap syndrome. 158
Autoimmune hepatitis/primary biliary cirrhosis overlap syndrome and associated extrahepatic autoimmune diseases. 157
DETECTION OF MND AND RL/M ANTI-NUCLEAR ANTIBODIES PATTERNS: A RELIABLE DIAGNOSTIC TOOL IN ANTI-MITOCHONDRIAL ANTIBODIES NEGATIVE PRIMARY BILIARY CIRRHOSIS. 157
Standardization of Autoantibody Testing in Autoimmune Hepatitis 157
Evidence of a genetic basis for the different geographic occurrences of liver/kidney microsomal antibody type 1 in hepatitis C. 156
Diagnostic approach to autoimmune hepatitis 155
Hepatocellular carcinoma in viral and autoimmune liver diseases: Role of CD4+ CD25+ Foxp3+ regulatory T cells in the immune microenvironment 155
Factors associated with response to therapy and outcome of patients with primary biliary cirrhosis with features of autoimmune hepatitis. 152
Multiple viral/self immunological cross-reactivity in liver kidney microsomal antibody positive hepatitis C virus infected patients is associated with the possession of HLA B51 150
International genome-wide meta-analysis identifies new primary biliary cirrhosis risk loci and targetable pathogenic pathways 149
Classical HLA-DRB1 and DPB1 alleles account for HLA associations with primary biliary cirrhosis. 145
Diagnosis of primary biliary cholangitis in a "teen" male patient 145
Hepatic steatosis in chronic hepatitis C: impact on response to anti-viral treatment with peg-interferon and ribavirin 144
Diagnostic and therapeutic implications of bile duct injury in autoimmune hepatitis. 141
Development of autoimmune hepatitis after influenza vaccination; trigger or killer? 141
Efficacy and Safety of Mycophenolate Mofetil and Tacrolimus as Second-line Therapy for Patients With Autoimmune Hepatitis. 140
Le fonti energetiche rinnovabili nel contesto internazionale: il solare fotovoltaico ed i suoi sviluppi tecnologici 139
Pathway-based analysis of primary biliary cirrhosis genome-wide association studies 139
Autoantibodies in antimithocondrial antibodies negative primary biliary cholangitis. 139
Tacrolimus and Mycophenolate Mofetil as Second-Line Therapies for Pediatric Patients with Autoimmune Hepatitis 138
Decompensated cirrhosis as presentation of LKM1/LC1 positive type 2 autoimmune hepatitis in adulthood. A rare clinical entity of difficult management 136
Numerical investigation of blood flow in a stenotic artery. Target 1: geometry and rheology 133
Response to Efe et al. 133
Serum Smooth Muscle Antibodies (SMA). 131
Usefulness of Antibodies to Deamidated Gliadin Peptides in Celiac Disease Diagnosis and Follow-up. 131
Update of the simplified criteria for autoimmune hepatitis: Evaluation of the methodology for immunoserological testing 130
Immunochip analyses identify a novel risk locus for primary biliary cirrhosis at 13q14, multiple independent associations at four established risk loci and epistasis between 1p31 and 7q32 risk variants. 129
Genetic distinction between autoimmune hepatitis in Italy and North America 128
Fatigue and pruritus at onset identify a more aggressive subset of primary biliary cirrhosis 128
Anti-neutrophil cytoplasm antibodies (ANCA) in autoimmune diseases: A matter of laboratory technique and clinical setting 128
Diagnostic role of anti-dsDNA antibodies: do not forget autoimmune hepatitis 126
Acute-on-chronic liver failure: A complex clinical entity in patients with autoimmune hepatitis 126
Diagnostic difficulties, therapeutic strategies, and performance of scoring systems in patients with autoimmune hepatitis and concurrent hepatitis B/C 124
Coronavirus disease associated immune thrombocytopenia: Causation or correlation? 123
Identification of new autoantigens by protein array indicates a role for IL4 neutralization in Autoimmune Hepatitis. 122
Current topics in autoimmune hepatitis. 122
Hepatitis C and autoreactivity. 120
Totale 17.596
Salva come PNG Salva come JPEG
Categoria #
all - tutte 59.432
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 59.432
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.048 0 0 0 0 0 0 0 0 0 129 92 827
2021/20222.455 211 49 169 220 201 124 50 168 100 177 567 419
2022/20232.442 326 342 128 314 139 186 87 135 388 95 189 113
2023/2024667 48 112 44 67 61 98 32 55 22 33 49 46
2024/20252.710 156 422 292 211 485 130 135 57 42 153 92 535
2025/20266.028 479 552 502 467 717 393 640 177 1.637 464 0 0
Totale 20.810